Abstracts tagged "race/ethnicity and rheumatoid arthritis (RA)"

Abstract Number: 1407 • 2018 ACR/ARHP Annual Meeting
Differences in the Measurement Properties of the Patient-Reported Outcomes Measurement Information System Physical Function Short-Form 10a Among Racial/Ethnic Minorities with Rheumatoid Arthritis
Zara Izadi¹, Patricia Katz², Gabriela Schmajuk³, Julie Gandrup⁴, Jing Li⁵, Milena Gianfrancesco⁶ and Jinoos Yazdany⁷, ¹Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, ²University of California San Francisco, San Francisco, CA, ³Medicine/Rheumatology, University of California - San Francisco, San Francisco, CA, ⁴Rheumatology, Odense University Hospital, Odense, Denmark, ⁵Medicine, UC San Francisco, San Francisco, CA, ⁶Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ⁷University of California, San Francisco, San Francisco, CA
Background/Purpose: Most studies evaluating patient-reported outcomes such as the PROMIS Physical Function Short Form 10a (PF10a) in rheumatoid arthritis (RA) have been performed in white…
Abstract Number: 557 • 2016 ACR/ARHP Annual Meeting
Differences in Clinical Outcomes in Different Socio-Economic and Racial Groups with Rheumatoid Arthritis: Data from National Inpatient Sample
Dilli Poudel¹, Rashmi Dhital², Abdullateef Abdulkareem³, Pragya Shrestha⁴ and Paras Karmacharya¹, ¹Internal Medicine, Reading Health System, WEST READING, PA, ²Universal College of Medical Sciences, MBBS, Kathmandu, Nepal, ³Inernal Medicine, Reading Health System, West Reading, PA, ⁴Internal medicine, Reading Health System, West Reading, PA
Background/Purpose: Studies have reported differences in healthcare utilization and outcome among different socioeconomic and ethnic groups. Complications like atherosclerotic cardiovascular diseases (ASCVD) have been documented…
Abstract Number: 508 • 2015 ACR/ARHP Annual Meeting
Impact of Race on Patient Global Scores and the Misclassification of Disease Activity
Shriyanka Jain¹, Uzma Khan¹, Amy Lundholm² and Martin Bergman³, ¹Internal Medicine, Mercy Catholic Medical Center, Darby, PA, ²Rheumatology, Roger Williams Medical Center, Providence, RI, ³Medicine, Drexel University College of Medicine, Philadelphia, PA
Background/Purpose: Disease activity measurement is a cornerstone of the Treat to Target strategy. However, all currently used measures include a Patient Global Score (PtGLB )…
Abstract Number: 2405 • 2014 ACR/ARHP Annual Meeting
Quality of Patient- Clinician Communication in a Diverse Cohort of Adults with Rheumatoid Arthritis
Jennifer Barton¹, Chris Tonner², Laura Trupin¹, Patricia P. Katz³ and Edward H. Yelin⁴, ¹Medicine, University of California, San Francisco, San Francisco, CA, ²3333 California Street, Box 09, University of California, San Francisco, San Francisco, CA, ³Medicine, University of California, San Francisco, CA, ⁴Arthritis Research Group, University of California, San Francisco, San Francisco, CA
Background/Purpose: To assess correlates of the quality of patient-clinician communication in a diverse cohort of adults with rheumatoid arthritis (RA). Methods: Data were obtained through…
Abstract Number: 1713 • 2013 ACR/ARHP Annual Meeting
Disparity In Biologic Therapy In Ethnic Minorities With Rheumatoid Arthritis: Can It All Be Due To Lack Of Access To Drug?
Gail S. Kerr¹, Ted R. Mikuls², Christopher J. Swearingen³, Chunqiao Luo⁴ and Yusuf Yazici⁵, ¹Rheumatology, Washington DC VAMC, Georgetown and Howard University, Washington, DC, ²Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, ³Pediatric Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR, ⁴Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, ⁵Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY
Background/Purpose: Ethnic disparities in the administration of DMARDs exist, but the impact of differing health care systems on access in ethnic minorities treated by rheumatologists,…
Abstract Number: 2514 • 2012 ACR/ARHP Annual Meeting
Racial/Ethnic Trends in Incidence and Prevalence of Rheumatoid Arthritis in a Large Multi-Ethnic Managed Care Population
Aniket A. Kawatkar¹, Cecilia Portugal¹, Li-Hao Chu² and Rajan Iyer³, ¹Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, ²Department of Research and Evaluation,, Kaiser Permanente Southern California, Pasadena, ³Department of Research and Evaluation,, Kaiser Permanente Southern California, Pasadena, CA
Background/Purpose: As epidemiologic studies throughout the world have shown significant variations, we sought to characterize racial differences in longitudinal epidemiologic trends of adult rheumatoid arthritis…
Abstract Number: 2138 • 2012 ACR/ARHP Annual Meeting
Racial and Ethnic Disparities in Rheumatoid Arthritis Outcomes in Community-Based U.S. Rheumatology Practices: Results From the Consortium of Rheumatology Researchers of North America Registry
Jeffrey D. Greenberg¹, Tanya Spruill², Gbenga Ogedebe³, Joel M. Kremer⁴, Ying Shan⁵, Katherine C. Saunders⁶, Yusuf Yazici⁷ and Leslie R. Harrold⁵, ¹NYU Hospital for Joint Diseases, New York, NY, ²Center for Healthful Behavior Change, Department of Population Health, NYU School of Medicine, New York, NY, ³New York University School of Medicine, New York, NY, ⁴Albany Medical College and The Center for Rheumatology, Albany, NY, ⁵Dept of Medicine, UMass Medical School, Worcester, MA, ⁶Corrona, LLC., Southborough, MA, ⁷New York University, New York, NY
Background/Purpose: Disparities in medication use and clinical outcomes have been reported in patients with rheumatoid arthritis (RA) and other chronic diseases. However, there is little…
Abstract Number: 1843 • 2012 ACR/ARHP Annual Meeting
Predictors of Starting and Stopping Disease Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis: A 23 Year Longitudinal Cohort
Daniel H. Solomon¹, Edward H. Yelin², Jeffrey N. Katz³, Chris Tonner⁴, M. Alan Brookhart⁵, Seoyoung C. Kim⁶, Bing Lu⁷ and John Z. Ayanian⁸, ¹Division of Rheumatology, Brigham and Women's Hospital, Boston, MA, ²Medicine, UC San Francisco, San Francisco, CA, ³Rheumatology and Orthopedics, Brigham & Women's Hospital, Boston, MA, ⁴Medicine, UCSF, San Francisco, CA, ⁵University of North Carolina, Chapel Hill, NC, ⁶Div. of Pharmacoepidemiology and Pharmacoeconomics, Div. of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ⁷Rheumatology, Brigham and Women's Hospital, Boston, MA, ⁸Brigham and Women's Hospital, Boston, MA
Background/Purpose: DMARDs are the standard of care for rheumatoid arthritis (RA), however multiple studies find that not all patients use these agents. We examined predictors…
Abstract Number: 57 • 2012 ACR/ARHP Annual Meeting
A British Survey of Time to Presentation and Treatment of Rheumatoid Arthritis in Subjects of Black and Minority Ethnic Origin
Sonia Panchal¹, Ash Samanta¹, Arumugam Moorthy¹, Sawson Hayat², Ira Pande², Adewale O. Adebajo³ and Kuntal Chakravarty⁴, ¹Rheumatology, University Hospitals of Leicester, Leicester, United Kingdom, ²Rheumatology, Nottingham University Hospitals, Nottingham, United Kingdom, ³Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, United Kingdom, ⁴Dept of Rheumatology, University of Bedfordshire Post Graduate Medical School, Romford, United Kingdom
Background/Purpose: National guidelines mandate urgent referral of rheumatoid arthritis (RA) for specialist treatment if more than three months from symptom onset; initial combination therapy with…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].